This Continuing Education activity is supported by an independent educational grant from Allergan Inc. and Prometheus Laboratories, Inc.
Marc G. Sturgill, PharmD
Advertisement
Articles by Marc G. Sturgill, PharmD
Advertisement
Latest Updated Articles
Irritable Bowel Syndrome: Helping Patients Access Appropriate Treatment in an Era of Investigation and DiscoveryPublished: November 17th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Interchangeability Designation to Denosumab Biosimilars Stoboclo and Osenvelt
2
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
3
Improving RSV Vaccine Coverage Could Prevent Thousands of Severe Cases in Older Adults
4
Recognizing Immunizing Pharmacists in the Community
5
